Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, December 26, 2024.
Arbutus Biopharma Corporation (NASDAQ:ABUS)
Strong Downtrend (-100) - ABUS is in a strong downtrend that is likely to continue. With short-term, intermediate, and long-term bearish momentum, ABUS continues to fall. Traders should use caution and set stops.
Is it time to buy, sell, or avoid ABUS?
MarketClub looks at technical strength and momentum to determine if the timing is right for ABUS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for ABUS
The long-term trend has been DOWN since Dec 3rd, 2024 at 3.385
The intermediate-term trend has been DOWN since Nov 6th, 2024 at 3.800
The short-term trend has been DOWN since Dec 12th, 2024 at 3.630
Smart Scan Analysis for ABUS
Based on our trend formula, ABUS is rated as a -100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 3.150 | 3.200 | 3.135 | 3.145 | -0.035 |
| Prev. Close | Volume | Bid | Ask | Time |
| 3.180 | 312544 | 2024-12-26 14:18:07 |
| Year High | 12.6 | Year High Date | 2018-08-02 |
| Year Low | 4.01 | Year Low Date | 2018-10-15 |
| 52wk High | 4.725 | 52wk High Date | 2024-09-09 |
| 52wk Low | 2.21 | 52wk Low Date | 2024-01-17 |
| Average Volume | 802,211 | Shares Outstanding | 189,492 |
| Market Cap | 103M | Assets | 140,441,000M |
| Liabilities | 33,551,000M | P/E Ratio | -3.08220000 |
| Volatility | 102.46 |